Scenario design for infectious disease projections: Integrating concepts from decision analysis and experimental design.

Design of experiments Multi-model projections Scenario modeling Sensitivity analysis Value of information

Journal

Epidemics
ISSN: 1878-0067
Titre abrégé: Epidemics
Pays: Netherlands
ID NLM: 101484711

Informations de publication

Date de publication:
24 May 2024
Historique:
received: 14 08 2023
revised: 04 04 2024
accepted: 20 05 2024
medline: 6 6 2024
pubmed: 6 6 2024
entrez: 5 6 2024
Statut: aheadofprint

Résumé

Across many fields, scenario modeling has become an important tool for exploring long-term projections and how they might depend on potential interventions and critical uncertainties, with relevance to both decision makers and scientists. In the past decade, and especially during the COVID-19 pandemic, the field of epidemiology has seen substantial growth in the use of scenario projections. Multiple scenarios are often projected at the same time, allowing important comparisons that can guide the choice of intervention, the prioritization of research topics, or public communication. The design of the scenarios is central to their ability to inform important questions. In this paper, we draw on the fields of decision analysis and statistical design of experiments to propose a framework for scenario design in epidemiology, with relevance also to other fields. We identify six different fundamental purposes for scenario designs (decision making, sensitivity analysis, situational awareness, horizon scanning, forecasting, and value of information) and discuss how those purposes guide the structure of scenarios. We discuss other aspects of the content and process of scenario design, broadly for all settings and specifically for multi-model ensemble projections. As an illustrative case study, we examine the first 17 rounds of scenarios from the U.S. COVID-19 Scenario Modeling Hub, then reflect on future advancements that could improve the design of scenarios in epidemiological settings.

Identifiants

pubmed: 38838462
pii: S1755-4365(24)00036-7
doi: 10.1016/j.epidem.2024.100775
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100775

Informations de copyright

Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest MCR reports stock ownership in Becton Dickinson & Co., which manufactures medical equipment used in COVID-19 testing, vaccination, and treatment. JL has served as an expert witness on cases where the likely length of the pandemic was of issue. There are no other competing interests to declare.

Auteurs

Michael C Runge (MC)

U.S. Geological Survey, Eastern Ecological Science Center at the Patuxent Research Refuge, Laurel, MD, USA. Electronic address: mrunge@usgs.gov.

Katriona Shea (K)

The Pennsylvania State University, University Park, PA, USA.

Emily Howerton (E)

The Pennsylvania State University, University Park, PA, USA.

Katie Yan (K)

The Pennsylvania State University, University Park, PA, USA.

Harry Hochheiser (H)

University of Pittsburgh, Pittsburgh, PA, USA.

Erik Rosenstrom (E)

North Carolina State University, Raleigh, NC, USA.

William J M Probert (WJM)

University of Oxford, Oxford, UK.

Rebecca Borchering (R)

The Pennsylvania State University, University Park, PA, USA.

Madhav V Marathe (MV)

University of Virginia, Charlottesville, VA, USA.

Bryan Lewis (B)

University of Virginia, Charlottesville, VA, USA.

Srinivasan Venkatramanan (S)

University of Virginia, Charlottesville, VA, USA.

Shaun Truelove (S)

Johns Hopkins University, Baltimore, MD, USA.

Justin Lessler (J)

The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Cécile Viboud (C)

Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.

Classifications MeSH